Roche Holding AG American Depositary Receipt (RHO0)

Profile

https://www.roche.com

Roche Holding AG American Depositary Receipt is a U.S. dollar-denominated security that represents ownership in Roche Holding AG, a leading Swiss healthcare company with a global presence. The primary function of this depositary receipt is to grant investors easy access to the economic benefits of holding shares in Roche, without the need to trade directly on foreign exchanges or deal with foreign currency complexities. Roche is distinguished by its dual focus: it operates major divisions in both pharmaceuticals and diagnostics, developing innovative medicines in oncology, immunology, infectious diseases, ophthalmology, and neuroscience, alongside state-of-the-art diagnostic technologies supporting diverse healthcare needs. This structure positions Roche as a key driver in the advancement of personalized medicine. The American Depositary Receipt streamlines cross-border investing by allowing participation in Roche’s performance—including rights to dividends, which are paid in U.S. dollars, and reduced safekeeping and administrative costs compared to direct foreign ownership. Roche’s significant role in global healthcare, underscored by its sustained R&D investment and collaboration with Genentech, cements its status among the world’s foremost biopharma and diagnostics companies, impacting healthcare delivery and innovation worldwide.